Embolic compositions and methods

Patent metadata

Field	Value
Publication number	US-2025360249-A1
Application number	US-202519297681-A
Country	US
Kind code	A1
Filing date	Aug 12, 2025
Priority date	May 15, 2018
Publication date	Nov 27, 2025
Grant date	—

Abstract

An embolization system and methods for controlling solidification of embolic compositions comprising a first and a second embolic component that react with each other in vivo at a target site to form an embolic material, with the embolic components being dilutable in physiological fluids so that they do not form an embolic composition at a site that is not desired.

First claim

What is claimed is:

1 . An embolization system comprising:
a catheter assembly comprising a first catheter and a distinct second catheter, a first liquid, a second liquid, an initiator, a co-initiator, with the initiator being disposed in one of the first liquid and the second liquid and the co-initiator being disposed in the other of the first liquid and the second liquid, a water soluble polymer disposed in at least one of the first liquid and the second liquid, the water soluble polymer comprising a plurality of functional groups, wherein the initiator and the co-initiator react to form a radical initiator upon mixing of the first and second liquids, and the radical initiator can initiate free radical polymerization of the functional groups to form a covalently crosslinked embolization material, and wherein the first catheter has an outer diameter ranging from 0.005 to 0.1 inches, the second catheter has an inner diameter ranging from 0.01 to 0.2 inches, and the first catheter is coaxially disposable inside the second catheter and slidably displaceable relative to the second catheter.

2 . The embolization system of claim 1 wherein the first liquid is deliverable from a first distal tip of the first catheter, the second liquid is deliverable from a second distal tip of the second catheter, and an offset distance between the first and second catheter distal tips is at least 2 mm.

3 . The embolization system of claim 2 wherein the offset distance is from 2 mm to 50 mm.

4 . The embolization system of claim 2 wherein the offset distance is from 2 mm to 10 mm.

5 . The embolization system of claim 1 further comprising a dual syringe.

6 . The embolization system of claim 5 wherein the dual syringe is operable by manual force.

7 . The embolization system of claim 1 further comprising a first flow metering control for the first liquid and/or a second flow metering control for the second liquid.

8 . The embolization system of claim 5 wherein the first and/or second flow metering controls are independently selected from the group consisting of a mechanically operable pump, a syringe pump, and a peristaltic pump.

9 . The embolization system of claim 5 wherein the first and/or second flow metering controls are independently adjustable to change a rate of flow while delivering the first and/or second liquids.

10 . The embolization system of claim 5 wherein the first and/or second flow metering controls are independently adjustable to change a rate of flow before delivery of the first and/or second liquids.

11 . The embolization system of claim 1 wherein a dilution of a mixture of the first liquid and the second liquid prevents formation of the embolization material in less than 120 seconds as measured by an in vitro gel time test, wherein the dilution is in a range of from 100% to 400% v/v.

12 . The embolization system of claim 1 wherein a 1:1 mixture of the first liquid and the second liquid forms the embolization material in no more than 5 seconds as measured by an in vitro gel time test.

13 . The embolization system of claim 1 wherein the embolization material is formed when the mixture is diluted 100%-250% v/v, wherein the embolization material is formed within 5 seconds when the mixture is diluted by less than 100% v/v, and wherein formation is measured by an in vitro gel time.

14 . The embolization system of claim 1 wherein the embolization material comprises a cohesive hydrogel with little or no adherence to the first or second catheters.

15 . The embolization system of claim 1 wherein the embolization material comprises a cohesive hydrogel having a swellability of 20%-300% w/w.

16 . The embolization system of claim 1 wherein the co-initiator is not in the same liquid as the initiator.

17 . The embolization system of claim 1 wherein the embolization material forms in vivo in no more than 5 seconds upon delivery of the first and second liquids at 1:1 v/v.

18 . The embolization system of claim 1 wherein the catheter assembly is configured to deliver the first and second liquids in tandem.

19 . The embolization system of claim 1 further comprising a catheter adaptor that connects the first and second catheters and provides a seal.

20 . The embolization system of claim 17 wherein the catheter adaptor comprises a Tuohy-Borst adaptor.

21 . A method of embolization comprising:
delivering in vivo the first and second liquids to a target lumen using the embolization system of claim 1 .

22 . The method of claim 19 wherein the target lumen comprises a blood vessel, organ, tumor, fibroid, cell mass, aneurysm, hypervascular tumor (cancerous or benign), aneurysm, aortic aneurysm, abdominal aortic aneurysm, peripheral aneurysm, hemostasis, vascular laceration, venous laceration, or tissue having a pathological condition.

Assignees

• Incept Llc

Inventors

• Sawhney Amarpreet S
• Claesson Hans
• Lareau Raymond
• Billings Douglas

Classifications

• C08F120/28

  containing no aromatic rings in the alcohol moiety · CPC title

• A61L2300/44

  Radioisotopes, radionuclides · CPC title

• A61L24/06

  obtained by reactions only involving carbon-to-carbon unsaturated bonds {(A61L24/043, A61L24/046 take precedence)} · CPC title

• A61L24/02

  containing inorganic materials · CPC title

• A61L24/0031

  Hydrogels or hydrocolloids · CPC title